Optimal reversal dose of Sugammadex in a short post-operative period in adult patients

Optimal reversal dose of Sugammadex in a short post-operative period in adult patients - Optimal dose of Sugammadex after rocuronium administration

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000007245

Enrollment

Registered

2012-02-15

Start date

2012-03-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

the patients scheduled for elective surgery requiring general anesthesia

Interventions

the group of rising T1 height over 10% after additional dosage of suggamadex the group of rising T1 height not over 10% after additional dosage of suggamadex

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: the patients scheduled for elective surgery requiring general anesthesia. the patients were ASA physical status 1-2.

Exclusion criteria

Exclusion criteria: the patients were ASA physical status 3-4. the diabetic patients. the patients who heve neurodegenerating disease.

Design outcomes

Primary

Measure	Time frame
Evaluation of neuromuscular responses with a peripheral neurostimulator	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026